Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

SB 45090.ª Legislatura (2027)

Relating to required labeling of food, medical, and cosmetic products containing, manufactured using, or derived from aborted human fetal tissue.

Introduced

El texto subrayado se agregaría a la ley vigente. El texto tachado se eliminaría.

  90R4506 JG-D
 
  By: Hall S.B. No. 450
 
 
  A BILL TO BE ENTITLED
  AN ACT
  relating to required labeling of food, medical, and cosmetic
  products containing, manufactured using, or derived from aborted
  human fetal tissue.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter D, Chapter 431, Health and Safety
  Code, is amended by adding Section 431.085 to read as follows:
         Sec. 431.085.  LABELING REQUIRED FOR FETAL TISSUE FOOD
  PRODUCT. (a) In this section:
               (1)  "Fetal tissue food product" means a food or food
  additive that:
                     (A)  contains human fetal tissue;
                     (B)  is manufactured using human fetal tissue; or
                     (C)  is otherwise derived from research using
  human fetal tissue.
               (2)  "Human fetal tissue" means tissue, cells,
  including cells from fetal cell lines, or organs obtained or
  originally derived from an aborted unborn child.
         (b)  A person may not sell in this state a fetal tissue food
  product unless the product is clearly and conspicuously labeled in
  accordance with department rules.
         (c)  The executive commissioner by rule shall prescribe the
  form and contents of the label required by Subsection (b).  The
  label must include the following statement in prominent type:  
  "This product either contains human fetal tissue, is manufactured
  using human fetal tissue, or is otherwise derived from research
  using human fetal tissue."
         SECTION 2.  Subchapter E, Chapter 431, Health and Safety
  Code, is amended by adding Section 431.119 to read as follows:
         Sec. 431.119.  LABELING REQUIRED FOR FETAL TISSUE MEDICAL
  PRODUCT. (a) In this section:
               (1)  "Fetal tissue medical product" means a medication,
  vaccine, or other medical product used in medical treatment that:
                     (A)  contains human fetal tissue;
                     (B)  is manufactured using human fetal tissue; or
                     (C)  is otherwise derived from research using
  human fetal tissue.
               (2)  "Human fetal tissue" means tissue, cells,
  including cells from fetal cell lines, or organs obtained or
  originally derived from an aborted unborn child.
         (b)  A person may not sell, dispense, or administer in this
  state a fetal tissue medical product unless the product is clearly
  and conspicuously labeled in accordance with department rules.
         (c)  The executive commissioner by rule shall prescribe the
  form and contents of the label required by Subsection (b).  The
  label must include the following statement in prominent type:  
  "This product either contains human fetal tissue, is manufactured
  using human fetal tissue, or is otherwise derived from research
  using human fetal tissue."
         SECTION 3.  Subchapter F, Chapter 431, Health and Safety
  Code, is amended by adding Section 431.143 to read as follows:
         Sec. 431.143.  LABELING REQUIRED FOR FETAL TISSUE COSMETIC
  PRODUCT. (a) In this section:
               (1)  "Fetal tissue cosmetic product" means a cosmetic
  product that:
                     (A)  contains human fetal tissue;
                     (B)  is manufactured using human fetal tissue; or
                     (C)  is otherwise derived from research using
  human fetal tissue.
               (2)  "Human fetal tissue" means tissue, cells,
  including cells from fetal cell lines, or organs obtained or
  originally derived from an aborted unborn child.
         (b)  A person may not sell in this state a fetal tissue
  cosmetic product unless the product is clearly and conspicuously
  labeled in accordance with department rules.
         (c)  The executive commissioner by rule shall prescribe the
  form and contents of the label required by Subsection (b).  The
  label must include the following statement in prominent type:  
  "This product either contains human fetal tissue, is manufactured
  using human fetal tissue, or is otherwise derived from research
  using human fetal tissue."
         SECTION 4.  (a) Not later than December 1, 2027, the
  executive commissioner of the Health and Human Services Commission
  shall adopt the form and content of the labels required under
  Sections 431.085, 431.119, and 431.143, Health and Safety Code, as
  added by this Act.
         (b)  Sections 431.085, 431.119, and 431.143, Health and
  Safety Code, as added by this Act, apply only to a fetal tissue
  food, medical, or cosmetic product sold, dispensed, or administered
  on or after January 1, 2028.
         SECTION 5.  This Act takes effect immediately if it receives
  a vote of two-thirds of all the members elected to each house, as
  provided by Section 39, Article III, Texas Constitution.  If this
  Act does not receive the vote necessary for immediate effect, this
  Act takes effect September 1, 2027.

Texto oficial de la Legislatura de Texas. El formato se adaptó para leerlo en Ratifi.